CVS Health (CVS) stock tumbles as earnings, guidance miss expectations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
CVS Health (CVS) PT Lowered to $77 at BofA Securities
May 2, 2024 5:38 AM EDTBofA Securities analyst Michael Cherny lowered the price target on CVS Health (NYSE: CVS) to $77.00 (from $95.00) while maintaining a Buy rating.
The analyst comments "Shares of CVS currently trade at 8x earnings, implying investors have substantial doubt the company can... More
CVS Health (CVS) Misses Q1 EPS by 38c; Lowers Outlook
May 1, 2024 6:34 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.33, $0.38 worse than the analyst estimate of $1.71. Revenue for the quarter came in at $88.4 billion versus the consensus estimate of $89.33 billion.
GUIDANCE:
CVS Health sees FY2024 EPS of $7.00, versus the consensus of... More
Fed meeting, Amazon results, struggling US consumers - what's moving markets
May 1, 2024 5:02 AM EDTInvesting.com -- The U.S. Federal Reserve concludes its latest policy-setting meeting later Wednesday, while Amazon's first-quarter results largely impressed. Crude prices have been hit by a large build in U.S. inventories, while Wall Street looks set to start the new month on a negative note.Â
1. Powell in focus as Fed meeting concludesThe Federal Reserve concludes its latest two-day policy meeting later in the session - the marquee event for markets this week.
The U.S. central bank is widely expected to... More
CVS Health (CVS) PT Lowered to $85 at UBS
April 29, 2024 6:18 AM EDTUBS analyst Kevin Caliendo lowered the price target on CVS Health (NYSE: CVS) to $85.00 (from $90.00) while maintaining a Buy rating.
The analyst comments " Our FY24 EPS estimate of $8.00 (prev. $8.24) falls based on our elevated MLR forecast for the full year (+40bps).... More
